Vaish Minal, Mandhani Anil, Mittal R D, Mittal Balraj
Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical sciences, RaiBariely Road, Lucknow- 226014, India.
BMC Urol. 2005 Jan 12;5:2. doi: 10.1186/1471-2490-5-2.
Carcinoma of urinary bladder is one of the leading causes of death in India. Successful treatment of bladder cancer depends on the early detection & specific diagnostic approaches. In the present study, microsatellite instability (MSI) has been evaluated as a prognostic marker in patients with superficial urinary bladder cancer in lower urinary tract for determining risk of recurrence.
A total of 44 patients with bladder tumors diagnosed with Transitional Cell Carcinomas [TCC] from lower urinary tract were selected for the study. Tumors were staged and graded according to AJCC-UICC (1997) classification and patients were followed with cystoscopy as per the protocol. Polymerase chain reaction (PCR) was done to amplify microsatellite sequences at mononucleotide BAT - 26, BAT - 40, TGFbeta RII, IGFIIR, hMSH3, BAX and dinucleotide D2S123, D9S283, D9S1851 and D18S58 loci in blood (control) and tumor DNA. PCR products were separated on 8% denaturing polyacrylamide gel and visualized by autoradiography.
MSI was observed in 72.7% of tumors at BAT - 26, BAT - 40, D2S123, D9S283, D9S1851 and D18S58 loci. Good association of MSI was seen with tumor stage and grade. MSI - High (instability at > 30% of loci) was frequently observed in high stage (40.6%) and high grade (59.4%) tumors. Of 24 tumors of Ta-T1 stage with different grades, 11 (9/18 high grade and 2/6 low grade tumors) recurred in the mean duration of 36 months. MSI positivity was significantly high in patients who had one or more recurrences (p = 0.02 for high grade and 0.04 for low grade tumors).
MSI may be an independent prognostic marker for assessing risk of recurrence in superficial tumors irrespective of the grade. Further studies on progression would help in stratifying the patients of T1G3 for early cystectomy vs bladder preservation protocol.
膀胱癌是印度主要的死亡原因之一。膀胱癌的成功治疗取决于早期检测和特定的诊断方法。在本研究中,微卫星不稳定性(MSI)已被评估为下尿路浅表性膀胱癌患者复发风险的预后标志物。
本研究共选取了44例被诊断为下尿路移行细胞癌(TCC)的膀胱肿瘤患者。根据AJCC-UICC(1997年)分类对肿瘤进行分期和分级,并按照方案对患者进行膀胱镜随访。采用聚合酶链反应(PCR)扩增血液(对照)和肿瘤DNA中位于单核苷酸BAT - 26、BAT - 40、TGFβRII、IGFIIR、hMSH3、BAX以及双核苷酸D2S123、D9S283、D9S1851和D18S58位点的微卫星序列。PCR产物在8%变性聚丙烯酰胺凝胶上分离,通过放射自显影进行可视化。
在BAT - 26、BAT - 40、D2S123、D9S283、D9S1851和D18S58位点,72.7%的肿瘤观察到MSI。MSI与肿瘤分期和分级有良好的相关性。高分期(40.6%)和高分级(59.4%)肿瘤中经常观察到高微卫星不稳定性(MSI-High,即>30%的位点不稳定)。在24例不同分级的Ta-T1期肿瘤中,11例(9/18高分级和2/6低分级肿瘤)在平均36个月的时间内复发。有一次或多次复发的患者中MSI阳性率显著较高(高分级肿瘤p = 0.02,低分级肿瘤p = 0.04)。
MSI可能是评估浅表性肿瘤复发风险的独立预后标志物,与分级无关。关于肿瘤进展的进一步研究将有助于对T1G3患者进行分层,以确定早期膀胱切除术与膀胱保留方案。